Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × Drug Therapy × Clear all

NCT06416930 2024-05-16

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

Phase 2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant